Patents by Inventor Jay A. Levy
Jay A. Levy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230012874Abstract: A sanitation device for cleaning a body of water in an immersion pool of a mikvah has a housing, a driving member and a bypass passageway. The housing includes an inlet, an outlet and internal liquid passages that communicate between the inlet and outlet. The driving member is arranged to urge flow of liquid through the internal liquid passages by exerting thrust upon liquid flowing through the driving member, wherein at least part of the liquid flowing through the liquid passages bypasses flowing through the driving member by flowing through the bypass passageway towards the device's outlet.Type: ApplicationFiled: July 14, 2022Publication date: January 19, 2023Inventors: Jonathan Jacob HELLER, Tomer Jay LEVY, Yishai SHMUEL Retyk
-
Patent number: 11371253Abstract: A sanitation device for cleaning a body of water in an immersion pool of a mikvah has a hollow member that extends along an axis X. In an operative position suitable for cleaning the device is arranged to extend generally immersed in the water and in a general upright orientation. The device further has an upper opening that in the operative position is arranged to be generally flush with the upper surface of the water and a propeller arranged to rotate about axis X and located at a lower region of the device that is arranged to form a downward flow that urges water to enter the device via the upper opening of the device.Type: GrantFiled: July 20, 2020Date of Patent: June 28, 2022Assignee: Pool Purity Ltd.Inventors: Jonathan Jacob Heller, Tomer Jay Levy
-
Patent number: 11286184Abstract: A generator (100, 101, 102, 103, 104, 105, 106, 107, 108, 109) is used for producing a treated oxygen containing gas for treating a body of matter (11). The generator (100, 101, 102, 103, 104, 105, 106, 107, 108, 109) extends along a generator axis and has an axially extending hollow sleeve (12) defining an internal space (14). At least one lid (16) is located at one of the axial ends of the sleeve (12) and a UV light source (18) and at least one magnet (20) are located along the axis.Type: GrantFiled: June 26, 2017Date of Patent: March 29, 2022Assignees: POOL PURITY LTD.Inventors: Jonathan Jacob Heller, Tomer Jay Levy
-
Publication number: 20210017781Abstract: A sanitation device for cleaning a body of water in an immersion pool of a mikvah has a hollow member that extends along an axis X. In an operative position suitable for cleaning the device is arranged to extend generally immersed in the water and in a general upright orientation. The device further has an upper opening that in the operative position is arranged to be generally flush with the upper surface of the water and a propeller arranged to rotate about axis X and located at a lower region of the device that is arranged to form a downward flow that urges water to enter the device via the upper opening of the device.Type: ApplicationFiled: July 20, 2020Publication date: January 21, 2021Inventors: Jonathan Jacob Heller, Tomer Jay Levy
-
Publication number: 20200325047Abstract: A generator (100, 101, 102, 103, 104, 105, 106, 107, 108, 109) is used for producing a treated oxygen containing gas for treating a body of matter (11). The generator (100, 101, 102, 103, 104, 105, 106, 107, 108, 109) extends along a generator axis and has an axially extending hollow sleeve (12) defining an internal space (14). At least one lid (16) is located at one of the axial ends of the sleeve (12) and a UV light source (18) and at least one magnet (20) are located along the axis.Type: ApplicationFiled: June 26, 2017Publication date: October 15, 2020Inventors: Jonathan Jacob HELLER, Tomer Jay LEVY
-
Publication number: 20190205473Abstract: Embodiments of the present invention provide a method, system and computer program product for social media influencer orchestration. In an embodiment of the invention, a method for social media influencer orchestration includes detecting a social media posting, such as a short burst message, an image or a comment upon an image, to a social media channel through a computing device by a subject end user, monitoring the social media channel to determine an impact of the social media posting and querying a rules base with the determined impact to retrieve a recommendation corresponding to the determined impact. Thereafter, a prompt is rendered in the computing device with the recommendation.Type: ApplicationFiled: December 29, 2017Publication date: July 4, 2019Inventors: Kelli Socol, Jay Levy
-
Publication number: 20160030518Abstract: The present disclosure provides methods of inhibiting viral activity in a cell, the methods generally involving contacting the cell with a soluble CD137 polypeptide or a FAM3C polypeptide. The present disclosure provides methods for treating a virus infection in an individual, the methods generally involving administering to the individual an effective amount of a soluble CD137 polypeptide or a FAM3C polypeptide.Type: ApplicationFiled: March 31, 2014Publication date: February 4, 2016Inventor: Jay A. Levy
-
Publication number: 20140258158Abstract: This invention allows users to record audio or video messages from a variety of sources and automatically distribute them to various websites. Additionally this invention automatically designates a quick response code, for each message, which links to a uniform resource locator for the recorded message so that the quick response code can be placed on printed media and scanned to access the recorded message. The uniform resource locator, associated with the quick response code can be prescheduled to automatically change based on a time or date.Type: ApplicationFiled: May 5, 2014Publication date: September 11, 2014Inventor: Norman Jay Levy
-
Publication number: 20120284649Abstract: This invention allows users to record audio or video messages from a variety of sources and automatically distribute them to various websites. Additionally this invention automatically designates a quick response code, for each message, which links to a uniform resource locator for the recorded message so that the quick response code can be placed on printed media and scanned to access the recorded message. The uniform resource locator, associated with the quick response code can be prescheduled to automatically change based on a time or date.Type: ApplicationFiled: May 2, 2012Publication date: November 8, 2012Inventor: Norman Jay Levy
-
Patent number: 5858374Abstract: A newly discovered family of AIDS-associated viruses, designated ARV, is described. The viruses were isolated from AIDS patients from San Francisco and (a) are type D retroviruses; (b) have Mg.sup.++ --dependent reverse transcriptase activity; (c) induce human multinucleated cells without immortalizing the cells; (d) are replicable in HUT-78 human T cells; and (e) induce viral protein(s) in HUT-78 that binds to Ig from AIDS patients. The infected HUT-78 cells and immunogenic polypeptides derived from the viruses are useful for diagnosing AIDS.Type: GrantFiled: June 7, 1995Date of Patent: January 12, 1999Assignee: University of CaliforniaInventor: Jay A. Levy
-
Patent number: 5736328Abstract: A newly discovered family of AIDS-associated viruses, designated ARV, is described. The viruses were isolated from AIDS patients from San Francisco and (a) are type D retroviruses; (b) have Mg.sup.++ -dependent reverse transcriptase activity; (c) induce human multinucleated cells without immortalizing the cells; (d) are replicable in HUT-78 human T cells; and (e) induce viral protein(s) in HUT-78 that binds to Ig from AIDS patients. The infected HUT-78 cells and immunogenic polypeptides derived from the viruses are useful for diagnosing AIDS.Type: GrantFiled: May 31, 1995Date of Patent: April 7, 1998Assignee: Regents of the University of CaliforniaInventor: Jay A. Levy
-
Patent number: 5707814Abstract: A protein secreted by peripheral blood mononuclear cells and specifically from CD8.sup.+ lymphocytes is purified and characterized here and designated CD8.sup.+ cell antiviral factor (CAF). The CAF is lipid free and has been found to inhibit the replication of retroviruses and in particular to inhibit the replication of HIV-1, HIV-2, and SIV. CAF can be used to inhibit viral RNA transcription which inhibits vital replication. Accordingly, CAF can be used to treat patients infected with retroviruses. The CAF can also generate antibodies which can be used to create assay devices for detecting CAF in a body fluid and on the surface of CD8.sup.+ cells to determine the condition of an HIV infected individual.Type: GrantFiled: March 5, 1996Date of Patent: January 13, 1998Assignee: The Regents of the University of CaliforniaInventors: Jay A. Levy, Carl E. Mackewicz
-
Patent number: 5580769Abstract: A protein secreted by peripheral blood mononuclear specifically from CD8.sup.+ lymphocytes is purified and characterized here and designated CD8.sup.+ cell antiviral factor (CAF). The CAF is lipid free and has been found to inhibit the replication of retroviruses and in particular to inhibit the replication of HIV-1, HIV-2, and SIV. CAF can be used to inhibit viral RNA transcription which inhibits viral replication. Accordingly, CAF can be used to treat patients infected with retroviruses. The CAF can also generate antibodies which can be used to create assay devices for detecting CAF in a body fluid and on the surface of CD8.sup.+ cells to determine the condition of an HIV infected individual.Type: GrantFiled: September 16, 1994Date of Patent: December 3, 1996Assignee: The Regents of The University of CaliforniaInventors: Jay A. Levy, Carl E. Mackewicz
-
Patent number: 5565549Abstract: A protein secreted by peripheral blood mononuclear cells and specifically from CD8.sup.+ lyphocytes is purified and characterized here and designated CD8.sup.+ cell antiviral factor (CAF). The CAF is lipid free, has a molecular weight of less than 30,000 and has been found to inhibit the replication of retroviruses and in particular to inhibit the replication of HIV-1, HIV-2, and SIV. CAF can be used to inhibit viral RNA transcription which inhibits viral replication. Accordingly, CAF can be used to treat patients infected with retroviruses. The CAF can also generate antibodies which can be used to create assay reagents for detecting CAF in a body fluid and on the surface of CD8.sup.+ cells to determine the condition of an HIV infected individual.Type: GrantFiled: September 17, 1993Date of Patent: October 15, 1996Assignee: The Regents Of The University Of CaliforniaInventors: Jay A. Levy, Carl E. Mackewicz
-
Patent number: 5543131Abstract: Strains of HIV-2 capable of infecting humans and non-human primates such as baboons and causing an immune system disease are disclosed. The HIV-2 strain are used to infect non-human primates which infected primates present symptoms of a disease of the immune system and are used to test drugs, e.g., anti-virals and/or vaccines for their ability to treat and/or prevent lentiviral infections such as HIV infections. Useful strains are HIV-2.sub.UC2, HIV-2.sub.UC12 and HIV-2.sub.UC14 and preferred non-human primates are baboons.Type: GrantFiled: August 5, 1994Date of Patent: August 6, 1996Assignee: The Regents of the University of CaliforniaInventor: Jay A. Levy
-
Patent number: 5538856Abstract: The subject invention permits diagnosis of chronic fatigue syndrome (CFS) by analyzing peripheral blood mononuclear cell subset populations and activation markers. A positive diagnosis for CFS is associated with an increase in the percentage of CD8+ cells showing CD38 or HLA-DR cell markers or a decrease in CD11b markers in CD8+ cells. The analysis is preferably performed using fluorochrome-labelled monoclonal antibodies specific for a determinant of the above subset cells and activation markers.Type: GrantFiled: March 7, 1995Date of Patent: July 23, 1996Assignee: The Regents of the University of CaliforniaInventors: Jay A. Levy, Alan L. Landay
-
Patent number: 5426028Abstract: The subject invention permits diagnosis of chronic fatigue syndrome (CFS) by analyzing peripheral blood mononuclear cell subset populations and activation markers. A positive diagnosis for CFS is associated with an increase in the percentage of CD8+ cells showing CD38 or HLA-DR cell markers or a decrease in CD11b markers in CD8+ cells. The analysis is preferably performed using fluorochrome-labelled monoclonal antibodies specific for a determinant of the above subset cells and activation markers.Type: GrantFiled: November 4, 1991Date of Patent: June 20, 1995Assignees: Rush-Presbyterian-St. Lukes Medical Center, The Regents of The University of CaliforniaInventors: Jay A. Levy, Alan L. Landay
-
Patent number: 4716102Abstract: A newly discovered family of AIDS-associated viruses, designated ARV, is described. The viruses were isolated from AIDS patients from San Francisco and (a) are type D retroviruses; (b) have Mg.sup.++ -dependent reverse transcriptase activity; (c) induce human multinucleated cells without immortalizing the cells; (d) are replicable in HUT-78 human T cells; and (e) induce viral protein(s) in HUT-78 that binds to Ig from AIDS patients. The infected HUT-78 cells and immunogenic polypeptides derived from the viruses are useful for diagnosing AIDS.Type: GrantFiled: August 15, 1984Date of Patent: December 29, 1987Assignee: Regents of the University of CaliforniaInventor: Jay A. Levy